Vanguard Group’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.94M | Buy |
2,293,988
+11,681
| +0.5% | +$30.3K | ﹤0.01% | 3150 |
|
|
2025
Q1 | $15.4M | Sell |
2,282,307
-1,152
| -0.1% | -$7.75K | ﹤0.01% | 2625 |
|
|
2024
Q4 | $15.5M | Buy |
2,283,459
+4,554
| +0.2% | +$30.9K | ﹤0.01% | 2716 |
|
|
2024
Q3 | $18.9M | Buy |
2,278,905
+103,292
| +5% | +$856K | ﹤0.01% | 2615 |
|
|
2024
Q2 | $13.8M | Buy |
2,175,613
+97,754
| +5% | +$620K | ﹤0.01% | 2745 |
|
|
2024
Q1 | $19.3M | Buy |
2,077,859
+11,417
| +0.6% | +$106K | ﹤0.01% | 2619 |
|
|
2023
Q4 | $26.3M | Buy |
2,066,442
+42,606
| +2% | +$543K | ﹤0.01% | 2473 |
|
|
2023
Q3 | $20.9M | Buy |
2,023,836
+19,364
| +1% | +$200K | ﹤0.01% | 2535 |
|
|
2023
Q2 | $26.3M | Sell |
2,004,472
-590,541
| -23% | -$7.74M | ﹤0.01% | 2476 |
|
|
2023
Q1 | $29M | Buy |
2,595,013
+175,393
| +7% | +$1.96M | ﹤0.01% | 2431 |
|
|
2022
Q4 | $20.4M | Sell |
2,419,620
-732,122
| -23% | -$6.17M | ﹤0.01% | 2620 |
|
|
2022
Q3 | $52.5M | Buy |
3,151,742
+18,232
| +0.6% | +$304K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $46.1M | Buy |
3,133,510
+516,991
| +20% | +$7.61M | ﹤0.01% | 2235 |
|
|
2022
Q1 | $64.9M | Buy |
2,616,519
+92,031
| +4% | +$2.28M | ﹤0.01% | 2173 |
|
|
2021
Q4 | $81M | Buy |
2,524,488
+72,373
| +3% | +$2.32M | ﹤0.01% | 2094 |
|
|
2021
Q3 | $88.2M | Buy |
2,452,115
+563,840
| +30% | +$20.3M | ﹤0.01% | 2049 |
|
|
2021
Q2 | $83.3M | Buy |
1,888,275
+746,635
| +65% | +$32.9M | ﹤0.01% | 2091 |
|
|
2021
Q1 | $52.2M | Buy |
1,141,640
+42,881
| +4% | +$1.96M | ﹤0.01% | 2287 |
|
|
2020
Q4 | $75.8M | Buy |
+1,098,759
| New | +$75.8M | ﹤0.01% | 1978 |
|